Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (361-370 of 480) with videos related to

Pageof 48
Sort By:
Bjpsych Open|December 19, 2024
The SLaM Brain Health Clinic: remote biomarker enhanced memory clinic for people with mild cognitive impairment within a National Health Service mental health trustAshwin V Venkataraman, Pooja Kandangwa, Roos Lemmen, et al.
International Journal of Geriatric Psychiatry|January 29, 2002
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesClive Ballard, Ian Powell, Ian James, et al.
The American Journal of Psychiatry|November 21, 2015
Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) ProgramClive Ballard, Martin Orrell, Sun YongZhong, et al.
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
Diagnostics (Basel, Switzerland)|May 4, 2026
Lifetime Exposure to Endogenous Estradiol and Markers of Dementia Risk: Associations with Later Life Cognitive, Behavioral, and Functional ComplaintsJasper F E Crockford, Dylan X Guan, Maryam Ghahremani, et al.
Journal of Neuroinflammation|May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementiasYuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Journal of the American Geriatrics Society|August 2, 2020
Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body DementiaMiguel Germán Borda, Dag Aarsland, Diego Alejandro Tovar-Rios, et al.
Archives of Gerontology and Geriatrics|May 13, 2026
Cross-sectional and longitudinal associations of self-perceptions of aging with physical activity in multimorbidity: The role of depressive symptomsFabrizio Mezza, Eugene Tang, Daniela Lemmo, et al.
Journal of Alzheimer'S Disease : JAD|March 9, 2017
Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaAmani Alghamdi, Julie Vallortigara, David R Howlett, et al.
The Journal of Pharmacy and Pharmacology|February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsSawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Pageof 48

Showing results (361-370 of 480) with videos related to

Sort By:
Pageof 48
Bjpsych Open|December 19, 2024
The SLaM Brain Health Clinic: remote biomarker enhanced memory clinic for people with mild cognitive impairment within a National Health Service mental health trustAshwin V Venkataraman, Pooja Kandangwa, Roos Lemmen, et al.
International Journal of Geriatric Psychiatry|January 29, 2002
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesClive Ballard, Ian Powell, Ian James, et al.
The American Journal of Psychiatry|November 21, 2015
Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) ProgramClive Ballard, Martin Orrell, Sun YongZhong, et al.
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
Diagnostics (Basel, Switzerland)|May 4, 2026
Lifetime Exposure to Endogenous Estradiol and Markers of Dementia Risk: Associations with Later Life Cognitive, Behavioral, and Functional ComplaintsJasper F E Crockford, Dylan X Guan, Maryam Ghahremani, et al.
Journal of Neuroinflammation|May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementiasYuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Journal of the American Geriatrics Society|August 2, 2020
Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body DementiaMiguel Germán Borda, Dag Aarsland, Diego Alejandro Tovar-Rios, et al.
Archives of Gerontology and Geriatrics|May 13, 2026
Cross-sectional and longitudinal associations of self-perceptions of aging with physical activity in multimorbidity: The role of depressive symptomsFabrizio Mezza, Eugene Tang, Daniela Lemmo, et al.
Journal of Alzheimer'S Disease : JAD|March 9, 2017
Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaAmani Alghamdi, Julie Vallortigara, David R Howlett, et al.
The Journal of Pharmacy and Pharmacology|February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsSawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Pageof 48